CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 22 filers reported holding CHINA BIOLOGIC PRODS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $32,997,000 | +33.0% | 306,890 | +53.9% | 0.01% | +25.0% |
| Q3 2016 | $24,819,000 | +133.9% | 199,382 | +99.8% | 0.00% | +100.0% |
| Q2 2016 | $10,609,000 | +354.0% | 99,786 | +508.3% | 0.00% | – |
| Q4 2015 | $2,337,000 | +1.6% | 16,405 | -36.0% | 0.00% | – |
| Q3 2015 | $2,301,000 | -90.4% | 25,623 | -87.7% | 0.00% | -100.0% |
| Q2 2015 | $23,944,000 | +235.0% | 207,916 | +177.8% | 0.00% | +300.0% |
| Q1 2015 | $7,148,000 | +116.7% | 74,842 | +52.5% | 0.00% | 0.0% |
| Q4 2014 | $3,299,000 | +6.7% | 49,077 | -14.3% | 0.00% | 0.0% |
| Q3 2014 | $3,091,000 | +17.3% | 57,283 | -3.4% | 0.00% | – |
| Q2 2014 | $2,636,000 | +31.3% | 59,287 | +2.6% | 0.00% | – |
| Q1 2014 | $2,008,000 | -19.9% | 57,794 | -33.5% | 0.00% | – |
| Q4 2013 | $2,506,000 | -6.2% | 86,875 | -5.1% | 0.00% | -100.0% |
| Q3 2013 | $2,673,000 | +4.4% | 91,511 | -17.1% | 0.00% | 0.0% |
| Q2 2013 | $2,560,000 | – | 110,403 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ariose Capital Management Ltd | 88,655 | $10,149,000 | 9.57% |
| WARBURG PINCUS LLC | 4,087,200 | $467,903,000 | 8.91% |
| RUDMAN ERROL M | 64,001 | $7,327,000 | 4.96% |
| INDUS CAPITAL PARTNERS, LLC | 378,518 | $43,333,000 | 4.22% |
| OBERWEIS ASSET MANAGEMENT INC/ | 90,105 | $10,315,000 | 2.98% |
| Ativo Capital Management LLC | 85,623 | $9,802,000 | 2.66% |
| Sensato Investors LLC | 113,296 | $12,970,000 | 2.31% |
| Cormorant Asset Management, LP | 111,500 | $12,765,000 | 1.92% |
| BARING ASSET MANAGEMENT Ltd | 128,784 | $14,743,000 | 1.23% |
| Visium Asset Management, LP | 484,619 | $55,479,000 | 0.94% |